(19)
(11) EP 4 798 175 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883167.9

(22) Date of filing: 22.10.2024
(51) International Patent Classification (IPC): 
A61K 9/48(2006.01)
A61K 9/72(2006.01)
 A61K 47/30(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0043; A61K 9/4833; A61K 9/4825
(86) International application number:
PCT/US2024/052338
(87) International publication number:
WO 2025/090448 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363545340 P

(71) Applicant: R.P. Scherer Technologies, LLC
Carson City, NV 89703 (US)

(72) Inventors:
  • SUKURU, Karunakar
    St. Petersburg, FL 33716 (US)
  • FANG, Qi
    St. Petersburg, FL 33716 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) CAPSULES FOR ORAL AND NASAL DELIVERY OF PHARMACEUTICAL PRODUCTS